Carbamazepine Treatment of Cocaine Dependence - 1 - Full Text View

Carbamazepine Treatment of Cocaine Dependence - 1

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Medical University of South Carolina
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000242

Purpose

The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.

Condition	Intervention	Phase
Cocaine-Related Disorders Substance-Related Disorders	Drug: Carbamazepine	Phase II

Drug Information available for:

8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Carbamazepine

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Carbamazepine Treatment of Cocaine Dependence

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Severity addiction
Amount of drug use
Affective stability
Medication compliance

Estimated Enrollment:	0
Study Start Date:	October 1992

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000242

Locations


United States, South Carolina
	Medical University of South Carolina
	Charleston, South Carolina, United States, 29425 742

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Medical University of South Carolina

Investigators


Principal Investigator:	Kathleen Brady, Ph.D.	Medical University of South Carolina

More Information

Publications:

(1) Brady KT et. al. Features of cocaine dependence with concurrent alcohol abuse. Drug and Alcohol Depend. 1995, 39(1):69-71. (2) Brady KT et. al. Personality disorder and assault history in substance-dependent individuals. Am J on Addictions. 1995, 4(4):306-312. (3) Dansky et. al. Use of self-report measures of crime-related posttraumatic stress disorder with substance use disordered patients. Journal of Substance Abuse Treatment. (in press). (4) Sonne an Presentation at CPDD meeting, 1996.

Study ID Numbers:	NIDA-07761-1, R29-07761-1
First Received:	September 20, 1999
Last Updated:	November 3, 2005
ClinicalTrials.gov Identifier:	NCT00000242
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders

Carbamazepine

Mental Disorders

Substance-Related Disorders

Disorders of Environmental Origin

Cocaine

Additional relevant MeSH terms:

Disease

Tranquilizing Agents

Physiological Effects of Drugs

Psychotropic Drugs

Central Nervous System Depressants

Antimanic Agents

Pharmacologic Actions

Pathologic Processes

Analgesics, Non-Narcotic

Sensory System Agents

Therapeutic Uses

Analgesics

Peripheral Nervous System Agents

Central Nervous System Agents

Anticonvulsants

ClinicalTrials.gov processed this record on October 29, 2008